S. Husain, C. Pietrangeli, and A. Zeevi, Delayed onset CMV disease in solid organ transplant recipients, Transplant Immunology, vol.21, issue.1, pp.1-9, 2009.
DOI : 10.1016/j.trim.2008.12.004

A. Rowshani, F. Bemelman, E. Van-leeuwen, R. Van-lier, and I. Ten-berge, Clinical and Immunologic Aspects of Cytomegalovirus Infection in Solid Organ Transplant Recipients, Transplantation, vol.79, issue.4, pp.381-386, 2005.
DOI : 10.1097/01.TP.0000148239.00384.F0

R. Fisher, Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation, Transplant Infectious Disease, vol.11, issue.3, pp.195-202, 2009.
DOI : 10.1111/j.1399-3062.2009.00372.x

D. Streblow, S. Orloff, and J. Nelson, Acceleration of allograft failure by cytomegalovirus, Current Opinion in Immunology, vol.19, issue.5, pp.577-582, 2007.
DOI : 10.1016/j.coi.2007.07.012

B. Adler and C. Sinzger, Endothelial cells in human cytomegalovirus infection: one host cell out of many or a crucial target for virus spread?, Thromb Haemost, vol.102, pp.1057-1063, 2009.

E. Guetta, E. Scarpati, and P. Dicorleto, Effect of cytomegalovirus immediate early gene products on endothelial cell gene activity, Cardiovascular Research, vol.50, issue.3, pp.538-546, 2001.
DOI : 10.1016/S0008-6363(01)00269-3

T. Sacher, C. Mohr, A. Weyn, C. Schlichting, and U. Koszinowski, The role of cell types in cytomegalovirus infection in vivo, European Journal of Cell Biology, vol.91, issue.1, pp.70-77, 2012.
DOI : 10.1016/j.ejcb.2011.02.002

R. Al-lamki, J. Bradley, and J. Pober, Endothelial Cells in Allograft Rejection, Transplantation, vol.86, issue.10, pp.1340-1348, 2008.
DOI : 10.1097/TP.0b013e3181891d8b

URL : http://pdfs.journals.lww.com/transplantjournal/2008/11270/Endothelial_Cells_in_Allograft_Rejection.2.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1505837043491;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdGlb2qsojlvlytk14LkMXSK3Le9nxpYI0C5OApZ5GYRQpXowCdY1rOm6k+pmg8OMG;hash|jzZZNKXo7uUtOkkek/C3Mw==

A. Amir, D. Orsogna, L. Roelen, D. Van-loenen, M. Hagedoorn et al., Allo-HLA reactivity of virus-specific memory T cells is common, Blood, vol.115, issue.15, pp.3146-3157, 2010.
DOI : 10.1182/blood-2009-07-234906

D. Orsogna, L. Roelen, D. Doxiadis, I. Claas, and F. , Alloreactivity from human viral specific memory T-cells, Transplant Immunology, vol.23, issue.4, pp.149-155, 2010.
DOI : 10.1016/j.trim.2010.06.008

L. Gamadia, E. Remmerswaal, S. Surachno, N. Lardy, and P. Wertheim-van-dillen, CROSS-REACTIVITY OF CYTOMEGALOVIRUS-SPECIFIC CD8+ T CELLS TO ALLO-MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULES, Transplantation, vol.77, issue.12, pp.1879-1885, 2004.
DOI : 10.1097/01.TP.0000131158.81346.64

A. Morice, B. Charreau, B. Neveu, S. Brouard, and J. Soulillou, Cross-Reactivity of Herpesvirus-Specific CD8 T Cell Lines Toward Allogeneic Class I MHC Molecules, PLoS ONE, vol.177, issue.8, p.12120, 2010.
DOI : 10.1371/journal.pone.0012120.t004

G. Pietra, C. Romagnani, M. Falco, M. Vitale, and R. Castriconi, The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR ??/??-mediated recognition, European Journal of Immunology, vol.172, issue.12, pp.3687-3693, 2001.
DOI : 10.1084/jem.172.5.1409

G. Pietra, C. Romagnani, C. Manzini, L. Moretta, and M. Mingari, T Lymphocytes in the Adaptive Immune Response to Pathogens and Tumors, Journal of Biomedicine and Biotechnology, vol.29, issue.1, p.907092, 2010.
DOI : 10.1084/jem.20091429

G. Pietra, C. Romagnani, P. Mazzarino, M. Falco, and E. Millo, HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes, Proceedings of the National Academy of Sciences, vol.45, issue.90003, pp.10896-10901, 2003.
DOI : 10.1093/jac/45.suppl_4.29

C. Romagnani, G. Pietra, M. Falco, E. Millo, and P. Mazzarino, Identification of HLA-E-specific alloreactive T lymphocytes: A cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells, Proceedings of the National Academy of Sciences, vol.295, issue.5562, pp.11328-11333, 2002.
DOI : 10.1126/science.1068440

R. Strong, M. Holmes, P. Li, L. Braun, and N. Lee, HLA-E Allelic Variants, Journal of Biological Chemistry, vol.160, issue.7, pp.5082-5090, 2003.
DOI : 10.1107/S0021889892009944

URL : http://www.jbc.org/content/278/7/5082.full.pdf

N. Lee, D. Goodlett, A. Ishitani, H. Marquardt, and D. Geraghty, HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences, J Immunol, vol.160, pp.4951-4960, 1998.

V. Braud, D. Allan, O. Callaghan, C. Soderstrom, K. et al., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C, Nature, vol.24, issue.6669, pp.795-799, 1998.
DOI : 10.1084/jem.178.4.1321

N. Lee, M. Llano, M. Carretero, A. Ishitani, and F. Navarro, HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A, Proceedings of the National Academy of Sciences, vol.5, issue.2, pp.5199-5204, 1998.
DOI : 10.1016/S1074-7613(00)80492-6

H. Hoare, L. Sullivan, G. Pietra, C. Clements, and E. Lee, Structural basis for a major histocompatibility complex class Ib???restricted T cell response, Nature Immunology, vol.59, issue.3, pp.256-264, 2006.
DOI : 10.1107/S0907444903008126

T. Van-hall, C. Oliveira, S. Joosten, and T. Ottenhoff, The other Janus face of Qa-1 and HLA-E: diverse peptide repertoires in times of stress, Microbes and Infection, vol.12, issue.12-13, pp.910-918, 2010.
DOI : 10.1016/j.micinf.2010.07.011

S. Joosten, K. Van-meijgaarden, P. Van-weeren, F. Kazi, and A. Geluk, Mycobacterium tuberculosis Peptides Presented by HLA-E Molecules Are Targets for Human CD8+ T-Cells with Cytotoxic as well as Regulatory Activity, PLoS Pathogens, vol.35, issue.2, p.1000782, 2010.
DOI : 10.1371/journal.ppat.1000782.t001

URL : https://doi.org/10.1371/journal.ppat.1000782

R. Salerno-goncalves, M. Fernandez-vina, D. Lewinsohn, and M. Sztein, Identification of a Human HLA-E-Restricted CD8+ T Cell Subset in Volunteers Immunized with Salmonella enterica Serovar Typhi Strain Ty21a Typhoid Vaccine, The Journal of Immunology, vol.173, issue.9, pp.5852-5862, 2004.
DOI : 10.4049/jimmunol.173.9.5852

P. Garcia, M. Llano, A. De-heredia, C. Willberg, and E. Caparros, Human T cell receptor-mediated recognition of HLA-E, European Journal of Immunology, vol.27, issue.4, pp.936-944, 2002.
DOI : 10.4049/jimmunol.164.10.5019

URL : https://hal.archives-ouvertes.fr/hal-00089996

D. Schulte, M. Vogel, B. Langhans, B. Kramer, and C. Korner, The HLA- E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) Issue 11 | e50951 infection and is associated with HLA-E-restricted recognition of an HCVderived peptide by interferon-gamma-secreting human CD8(+) T cells, J Infect Dis, vol.7, issue.200, pp.1397-1401, 2009.

M. Sensi, G. Pietra, A. Molla, G. Nicolini, and C. Vegetti, Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5, International Immunology, vol.177, issue.5, pp.257-268, 2009.
DOI : 10.4049/jimmunol.177.5.3100

H. Jiang, S. Canfield, M. Gallagher, H. Jiang, and Y. Jiang, HLA-E???restricted regulatory CD8+ T cells are involved in development and control of human autoimmune type 1 diabetes, Journal of Clinical Investigation, vol.120, issue.10, pp.3641-3650, 2010.
DOI : 10.1172/JCI43522DS1

C. Oliveira, P. Van-veelen, B. Querido, A. De-ru, and M. Sluijter, T cell surveillance of antigen-processing defects, The Journal of Experimental Medicine, vol.163, issue.1, pp.207-221, 2010.
DOI : 10.1097/00002371-200003000-00001

S. Coupel, A. Moreau, M. Hamidou, V. Horejsi, and J. Soulillou, Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation, Blood, vol.109, pp.2806-2814, 2007.
DOI : 10.1182/blood-2006-06-030213

R. Pacasova, S. Martinozzi, H. Boulouis, M. Ulbrecht, and J. Vieville, Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice, J Immunol, vol.162, pp.5190-5196, 1999.

X. Saulquin, C. Ibisch, M. Peyrat, E. Scotet, and M. Hourmant, A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening, European Journal of Immunology, vol.30, issue.9, pp.2531-2539, 2000.
DOI : 10.1002/1521-4141(200009)30:9<2531::AID-IMMU2531>3.0.CO;2-O

N. Gervois, N. Labarriere, L. Guiner, S. Pandolfino, M. Fonteneau et al., High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells, Clin Cancer Res, vol.6, pp.1459-1467, 2000.

S. Coupel, F. Leboeuf, G. Boulday, J. Soulillou, and B. Charreau, RhoA Activation Mediates Phosphatidylinositol 3-Kinase-Dependent Proliferation of Human Vascular Endothelial Cells: An Alloimmune Mechanism of Chronic Allograft Nephropathy, Journal of the American Society of Nephrology, vol.15, issue.9, pp.2429-2439, 2004.
DOI : 10.1097/01.ASN.0000138237.42675.45

V. Braud, D. Allan, D. Wilson, and A. Mcmichael, TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide, Current Biology, vol.8, issue.1, pp.1-10, 1998.
DOI : 10.1016/S0960-9822(98)70014-4

E. De-plaen, C. Lurquin, B. Lethe, P. Van-der-bruggen, and V. Brichard, Identification of Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes, Methods, vol.12, issue.2, pp.125-142, 1997.
DOI : 10.1006/meth.1997.0462

C. Klebanoff, L. Gattinoni, and N. Restifo, CD8+ T-cell memory in tumor immunology and immunotherapy, Immunological Reviews, vol.61, issue.1, pp.214-224, 2006.
DOI : 10.1016/j.coi.2005.02.002

URL : http://europepmc.org/articles/pmc1501075?pdf=render

C. Cerboni, M. Mousavi-jazi, H. Wakiguchi, E. Carbone, and K. Karre, Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell, 2001.

P. Tomasec, V. Braud, C. Rickards, M. Powell, and B. Mcsharry, Surface Expression of HLA-E, an Inhibitor of Natural Killer Cells, Enhanced by Human Cytomegalovirus gpUL40, Science, vol.287, issue.5455, p.1031, 2000.
DOI : 10.1126/science.287.5455.1031

G. David, M. Morvan, K. Gagne, N. Kerdudou, and C. Willem, Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies, Immunology, vol.26, issue.2, pp.172-184, 2009.
DOI : 10.1111/j.1365-2249.2007.03424.x

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2567.2009.03085.x/pdf

A. Moesta, P. Norman, M. Yawata, N. Yawata, and M. Gleimer, Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3, The Journal of Immunology, vol.180, issue.6, pp.3969-3979, 2008.
DOI : 10.4049/jimmunol.180.6.3969

D. Pende, S. Marcenaro, M. Falco, S. Martini, and M. Bernardo, Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity, Blood, vol.113, issue.13, pp.3119-3129, 2009.
DOI : 10.1182/blood-2008-06-164103

URL : https://hal.archives-ouvertes.fr/hal-00407847

K. Schonberg, M. Sribar, J. Enczmann, J. Fischer, and M. Uhrberg, Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition, Blood, vol.117, issue.1, pp.98-107, 2011.
DOI : 10.1182/blood-2010-03-273656

J. Rodgers and R. Cook, MHC class Ib molecules bridge innate and acquired immunity, Nature Reviews Immunology, vol.188, issue.6, pp.459-471, 2005.
DOI : 10.1084/jem.188.5.961

L. Sullivan, C. Clements, J. Rossjohn, and A. Brooks, The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity, Tissue Antigens, vol.99, issue.5, pp.415-424, 2008.
DOI : 10.4049/jimmunol.173.9.5852

M. Reddehase, Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance, Nature Reviews Immunology, vol.73, issue.11, pp.831-844, 2002.
DOI : 10.1006/viro.2001.1335

G. Wilkinson, P. Tomasec, R. Stanton, M. Armstrong, and V. Prod-'homme, Modulation of natural killer cells by human cytomegalovirus, Journal of Clinical Virology, vol.41, issue.3, pp.206-212, 2008.
DOI : 10.1016/j.jcv.2007.10.027

P. Mazzarino, G. Pietra, P. Vacca, M. Falco, and D. Colau, Identification of effector-memory CMV-specific T???lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion, European Journal of Immunology, vol.158, issue.11, pp.3240-3247, 2005.
DOI : 10.4049/jimmunol.169.10.5838

L. Moretta, C. Romagnani, G. Pietra, A. Moretta, and M. Mingari, NK-CTLs, a novel HLA-E-restricted T-cell subset, Trends in Immunology, vol.24, issue.3, pp.136-143, 2003.
DOI : 10.1016/S1471-4906(03)00031-0

B. Jabri, J. Selby, H. Negulescu, L. Lee, and A. Roberts, TCR Specificity Dictates CD94/NKG2A Expression by Human CTL, Immunity, vol.17, issue.4, pp.487-499, 2002.
DOI : 10.1016/S1074-7613(02)00427-2

URL : https://doi.org/10.1016/s1074-7613(02)00427-2

S. Takemoto, F. Port, F. Claas, and R. Duquesnoy, HLA matching for kidney transplantation, Human Immunology, vol.65, issue.12, pp.1489-1505, 2004.
DOI : 10.1016/j.humimm.2004.06.008

J. Van-bergen, A. Thompson, G. Haasnoot, J. Roodnat, and J. De-fijter, KIR-Ligand Mismatches Are Associated With Reduced Long-Term Graft Survival in HLA-Compatible Kidney Transplantation, American Journal of Transplantation, vol.10, issue.9, pp.1959-1964, 2011.
DOI : 10.1111/j.1600-6143.2010.03242.x